Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 08, 2018 17:23 ET | Source: Cidara Therapeutics, Inc.

Cidara Provides Corporate Update and Reports Third Quarter 2018 Financial Results

SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
September 24, 2018 16:05 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics to Present at Two Upcoming Investor Conferences

SAN DIEGO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that...
May 21, 2018 07:30 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics Announces Offering of Common Stock and Warrants

SAN DIEGO, May 21, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it has...
March 01, 2018 16:05 ET | Source: Cidara Therapeutics, Inc.

Cidara Announces Appointment of Chrysa Mineo as Independent Director

SAN DIEGO, March 01, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the...
February 27, 2018 16:32 ET | Source: Cidara Therapeutics, Inc.

Cidara Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results

SAN DIEGO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
November 08, 2017 16:01 ET | Source: Cidara Therapeutics, Inc.

Cidara Provides Corporate Update and Reports Third Quarter 2017 Financial Results

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...